ABSTRACT
With almost one billion adults estimated globally to have obstructive sleep apnea (OSA) and hundreds of millions affected by chronic lung diseases worldwide, recognizing and understanding the impact of sleep and sleep-disordered breathing (SDB) on chronic lung diseases and vice versa is essential.
Obstructive lung diseases are associated with a higher prevalence of sleep problems. The association of asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease with SDB has been associated with compromised sleep quality, impaired daytime functioning, nocturnal desaturation, poor clinical outcomes, poor quality of life, and high health resource utilization.
We conclude by emphasizing that a comprehensive sleep evaluation should be included in the evaluation of any patient with chronic lung disease. Additional research is also needed to delineate the complex relationship between the different phenotypes and severities of SDB and chronic lung disease better.
